SNDX
Syndax Pharmaceuticals Inc
NASDAQ · Biotechnology
$21.01
+0.86 (+4.27%)
Open$20.48
Previous Close$20.15
Day High$21.25
Day Low$20.25
52W High$22.73
52W Low$8.58
Volume—
Avg Volume1.34M
Market Cap1.83B
P/E Ratio—
EPS$-3.60
SectorBiotechnology
Analyst Ratings
Strong Buy
20 analysts
Price Target
+16.6% upside
Current
$21.01
$21.01
Target
$24.49
$24.49
$15.15
$24.49 avg
$32.88
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 24.04M | 43.44M | 335.52M |
| Net Income | -323,566,532 | -526,219,513 | -86,065,429 |
| Profit Margin | -1,346.1% | -1,278.8% | -25.7% |
| EBITDA | -345,043,187 | -592,322,059 | -127,710,433 |
| Free Cash Flow | — | — | -48,776,040 |
| Rev Growth | -44.7% | -44.7% | -8.5% |
| Debt/Equity | 1.19 | 1.19 | 0.60 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |